Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

ValiRx (VAL)

Price 1.90p on 22-10-2024 at 16:30:01
Change -0.25p -11.63%
Buy 2.00p
Sell 1.80p
Buy / Sell VAL Shares
Last Trade: Sell 70,000.00 at 1.84p
Day's Volume: 9,772,902
Last Close: 1.90p
Open: 2.15p
ISIN: GB00BLH13C52
Day's Range 1.90p - 2.00p
52wk Range: 1.225p - 14.75p
Market Capitalisation: £3m
VWAP: 2.011667p
Shares in Issue: 132m

Recent Trades History ValiRx (VAL)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 70,000 1.84p Ordinary
16:30:12 - 22-Oct-24
Sell* 414,691 1.845p Ordinary
16:29:01 - 22-Oct-24
Sell* 54,200 1.845p Ordinary
16:12:03 - 22-Oct-24
Sell* 30,000 1.85p Ordinary
16:05:30 - 22-Oct-24
Sell* 10,000 1.812p Ordinary
15:52:03 - 22-Oct-24
Sell* 15,000 1.875p Ordinary
14:28:50 - 22-Oct-24
Sell* 25,000 1.80p Ordinary
14:27:30 - 22-Oct-24
Sell* 30,000 1.80p Ordinary
14:23:11 - 22-Oct-24
Sell* 8,744 1.80p Ordinary
14:19:17 - 22-Oct-24
Sell* 12,434 1.89p Ordinary
14:19:03 - 22-Oct-24

Share Price History for ValiRx

Time period:
to
Date Open High Low Close Volume

Share News for ValiRx

EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart

27th Sep 2024 13:56

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

TRADING UPDATES: Light Science Technologies wins two new contracts

9th Sep 2024 22:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx

12th Aug 2024 12:01

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced in August so far and not separately reported by Alliance News: Read More

EXECUTIVE CHANGES: Jadestone Energy's CFO Bert-Jaap Dijkstra to leave

3rd Jul 2024 18:33

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: ValiRx shares up as subsidiary inks contract with US firm

17th Jun 2024 14:29

ValiRx PLC - life sciences company focused on early-stage cancer therapeutics and women's health - Notes that its subsidiary Inaphaea BioLabs Limited wins a "revenue-bearing" contract for the provision of patient derived cell based services with a US-based biotech company. "The contract is a multi-stage project and encompasses analysis and provision of RNA data, acquired as part of the scientific package from Imagen Therapeutics, in addition to bespoke cell-based screening in the laboratory," ValiRx explains. Read More

FTSE 100 Latest
Value8,306.54
Change-11.70

Login to your account

Forgot Password?

Not Registered